DC Politics DC
Pfizer tops Q1 expectations, revises 2022 forecast
Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%. The coronavirus vaccine Comirnaty brought in…
